Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symptomology Changes With Systane PRO PF Versus Thealoz Duo
NCT07451184Phase 4Completed
- Sponsor
- University of Waterloo
- Start
- Feb 2026
- Primary completion
- Aug 2026
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Phase 4, randomised trial of Systane PRO and sodium hyaluronate + trehalose in dry eye syndrome (DED) (2 arms), sponsored by University of Waterloo. Primary endpoint: Ocular Surface Disease Index Score at 4 weeks. Started Feb 2026; status: completed.
02
Drugs
Systane PROsodium hyaluronate + trehalose
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT07451184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07451184.